The pore-forming α-subunit of the cardiac voltage-gated sodium channel, NaV1.5, is responsible for the initial upstroke of the cardiac action potential. NaV1.5 cell surface expression and function are modulated by its interaction with regulatory proteins and by posttranslational modifications, such as phosphorylation, arginine methylation or ubiquitination 1. Genetic mutations in the SCN5A gene, which encodes NaV1.5, have been associated with a variety of inherited cardiac arrhythmias, including long QT syndrome type 3, Brugada syndrome, atrial fibrillation, and congenital sick sinus syndrome. In addition, abnormal NaV1.5 plasma membrane expression or sodium current (INa) density have also been observed in acquired cardiac disorders, such as heart failure (HF), although the molecular mechanisms that trigger these alterations are not well understood.
This article is protected by copyright. All rights reserved.